Journal of Advanced Pharmaceutical Technology & Research

REVIEW ARTICLE
Year
: 2012  |  Volume : 3  |  Issue : 2  |  Page : 92--99

Hydroxamic acid - A novel molecule for anticancer therapy


Dilipkumar Pal1, Supriyo Saha2 
1 Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, Guru GhasidashVishwavidyalaya (A Central University), Koni, Bilashpur, India
2 Department of Pharmaceutical Chemistry, Himalayan Institute of Pharmacy and Research, Rajawala, Dehradun, India

Correspondence Address:
Dilipkumar Pal
Associate Professor, Institute of Pharmaceutical Sciences, Guru Ghasidash Vishwavidyalaya (A Central University), Koni, Bilashpur, C.G - 495 009
India

Hydroxamic acid is a potent moiety not only in the field of cancer therapy but also as a mutagenic agent. Among the various derivatives of hydroxamic acid, SAHA (Suberoylanilide Hydroxamic Acid) is considered as a potent anticancer agent. Scientists from the different corner synthesized different hydroxamic acid moieties with some straight chain oxazole, thiadiazole, biphenyl moieties in the terminal position. Acetylation and deacetylation of histones of the core proteins of nucleosomes in chromatin play an important role in the regulation of gene expression. The level of acetylation of histones is established and maintained by two classes of enzymes, histone acetyltransferase and histone deacetylases, which have been identified as transcriptional coactivators and transcriptional corepressors, respectively. There is increasing evidence that aberrant histone acetylation has been linked to various malignant diseases. Great efforts are currently underway for the design of more potent and less toxic candidates for the treatment of cancer. In recent years, hydroxamic acid derivatives have attracted increasing attention for their potential as highly efficacious in combating various etiological factors associated with cancer. Our main intention to draw an attention is that this single functional moiety has not only fit in the receptor but also create a diversified activity.


How to cite this article:
Pal D, Saha S. Hydroxamic acid - A novel molecule for anticancer therapy.J Adv Pharm Technol Res 2012;3:92-99


How to cite this URL:
Pal D, Saha S. Hydroxamic acid - A novel molecule for anticancer therapy. J Adv Pharm Technol Res [serial online] 2012 [cited 2021 Oct 20 ];3:92-99
Available from: https://www.japtr.org/article.asp?issn=2231-4040;year=2012;volume=3;issue=2;spage=92;epage=99;aulast=Pal;type=0